A letter to the editor is presented in response to the previous article "The Comparative Efficacy and Safety of Piginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-analysis," by S. M. Alavian, B. Behnave and S. V. Tabatabaei.